Document is current
Any future updates will be listed below
-
Authors
Parish, Maclaine A.
Sachithanandham, Jaiprasath
Gutierrez, Lizeth
Park, Han-Sol
Yin, Anna
Roznik, Katerina
Creisher, Patrick
Lee, John S.
St Clair, Laura A.
Werner, Annie
Pilgrim-Grayson, Catherine
Berhane, Lea
Golding, Hana
Shea, Patrick
Fenstermacher, Katherine
Rothman, Richard
Burd, Irina
Sheffield, Jeanne
Cox, Andrea L.
Pekosz, Andrew
Klein, Sabra L.
-
Funding
Funding for this research was provided by:
FDA (U01FD005946)
FDA (U01FD005946)
FDA (U01FD005946)
FDA (U01FD005946)
FDA (U01FD005946)
FDA (U01FD005946)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Institute of Allergy and Infectious Diseases (75N93021C00045)
National Cancer Institute (U54CA260492)
National Cancer Institute (U54CA260492)
National Cancer Institute (U54CA260492)
National Cancer Institute (U54CA260492)
National Cancer Institute (U54CA260492)
National Cancer Institute (U54CA260492)
National Cancer Institute (U54CA260492)
- License Information
-
More Information
Article History
Received: 28 March 2025
Accepted: 15 July 2025
First Online: 13 August 2025
Competing interests
: The authors declare no competing interests.
